Notify me when Christopher Haqq files a new Insider Trading report.
⭐ Subscribe ⭐| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SRZN, SRZNW | Surrozen, Inc./DE | Former Director | $11,400 | 11 Aug 2021 | ||
| ELTX | Elicio Therapeutics, Inc. | Executive Vice President, Head of R&D and Chief Medical Officer | 03 Feb 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|